Track Doximity, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Doximity, Inc. DOCS · Stock Open Doximity, Inc. in new tab

33.34 USD
P/E
46.14
EPS
0.72
P/B
6.38
ROE
13.81
Beta
1.29
Target Price
31.22 USD
Doximity, Inc. logo

Doximity, Inc.

🧾 Earnings Recap – Q2 2027

Doximity’s shares fell 2.0% after earnings, a roughly flat reaction. Revenue and adjusted EBITDA margin were above the company’s guidance range, while workflow-prescriber growth accelerated and AI adoption expanded; the available transcript does not provide the full outlook or enough evidence to identify a specific disappointment.

  • Q2 revenue was $175 million, up 4% year over year and 2 percentage points above the high end of guidance.
  • Adjusted EBITDA was $89 million, with a 51% margin—9 percentage points above the high end of guidance—even as AI spending grew more than 6x year over year.
  • Quarterly active workflow prescribers grew 34% year over year to a record, reaching approximately half of the 1.8 million U.S. prescribers.
  • The health-system AI client base topped 190, up from 165 the prior quarter; 10 of the nation’s top 20 hospitals were clients.
  • Pharma AI search had been purchased by 16 of the top 20 pharma companies, with three more in contracting.
📅
Loading chart...
Key Metrics
Earnings dateFeb. 4, 2027
P/E46.14
EPS0.72
Book Value5.21
Price to Book6.38
Debt/Equity0.99
% Insiders2.978%
Growth
Revenue Growth0.04%
Earnings Growth-0.42%
Estimates
Forward P/E21.43
Forward EPS1.55
Target Mean Price31.22

DCF valuation

Model fair value for Doximity, Inc. (DOCS)
Result
Sign in to run the valuation for DOCS.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
18 analysts · consensus Hold · mean target 31.22 USD (low 18.00, high 41.00) · as of 12 Nov 2026
Low 18.00
Mean 31.22
High 41.00
Price 33.34
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

Doximity, Inc. Logo Doximity, Inc. Analysis (DOCS)

Is Doximity, Inc. a good investment? Doximity, Inc. (DOCS) is currently trading at 33.34 USD. Market analysts have a consensus price target of 31.22 USD. This suggests the asset is currently trading above analyst expectations.

In terms of valuation, the stock trades at a P/E ratio of 46.14. This high multiple suggests investors have priced in significant future growth expectations.

Earnings Schedule: Doximity, Inc. is expected to release its next earnings report on Feb. 4, 2027. The market consensus estimate for Forward EPS is 1.55.

Investor FAQ

Does Doximity, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Doximity, Inc.?

Doximity, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be Feb. 4, 2027. The company currently has a trailing EPS of 0.72.

Company Profile

Doximity, Inc. operates a digital platform for medical professionals in the United States. Its Doximity platform includes a personalized newsfeed that presents clinical and professional content to members, which offers medical articles, clinical trials or research results in an easy-to-consume video format, professional updates and accomplishments of their peers and colleagues, clinical discussions, Op-Med articles for publication, and sponsored content from pharmaceutical manufacturers and health systems. The company also offers workflow tools, including Ask, a HIPAA-compliant AI assistant, to access and apply evidence-based medical information within clinical workflows; Scribe, a HIPAA-compliant, AI-powered clinical documentation tool; Telehealth tools for hospitals and health systems; and AMiON, an on-call scheduling tool. The company primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

Exchange Ticker
DOCS
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion